AFM
CVS icon

Abbot Financial Management’s CVS Health CVS Stock Holding History

Abbot Financial Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,952
Closed -$794K – 128
2024
Q1 		$794K Sell
9,952
-428
-4% -$32.7K 0.44% 66
2023
Q4 		$820K Sell
10,380
-8,852
-46% -$630K 0.49% 61
2023
Q3 		$1.34M Sell
19,232
-1,604
-8% -$114K 0.9% 35
2023
Q2 		$1.44M Sell
20,836
-662
-3% -$47.1K 0.92% 35
2023
Q1 		$1.6M Buy
21,498
+653
+3% +$54.8K 1.07% 31
2022
Q4 		$1.94M Sell
20,845
-760
-4% -$73.3K 1.33% 26
2022
Q3 		$2.06M Sell
21,605
-299
-1% -$29.6K 1.47% 22
2022
Q2 		$2.03M Buy
21,904
+502
+2% +$49K 1.23% 28
2022
Q1 		$2.17M Buy
21,402
+3,513
+20% +$369K 1.06% 34
2021
Q4 		$1.84M Sell
17,889
-273
-2% -$25.2K 0.82% 38
2021
Q3 		$1.54M Buy
18,162
+2
+0% +$168 0.7% 42
2021
Q2 		$1.51M Sell
18,160
-327
-2% -$26.8K 0.66% 43
2021
Q1 		$1.39M Buy
18,487
+1,010
+6% +$73.6K 0.63% 45
2020
Q4 		$1.19M Sell
17,477
-519
-3% -$33.8K 0.69% 46
2020
Q3 		$1.05M Buy
17,996
+638
+4% +$39.7K 0.68% 47
2020
Q2 		$1.13M Sell
17,358
-123
-0.7% -$7.75K 0.78% 42
2020
Q1 		$1.04M Buy
17,481
+2
+0% +$134 0.84% 36
2019
Q4 		$1.3M Buy
17,479
+2,183
+14% +$153K 0.82% 37
2019
Q3 		$965K Buy
15,296
+401
+3% +$23.8K 0.69% 48
2019
Q2 		$812K Sell
14,895
-2,524
-14% -$136K 0.59% 57
2019
Q1 		$939K Buy
17,419
+2,581
+17% +$159K 0.73% 51
2018
Q4 		$972K Buy
14,838
+798
+6% +$59.6K 0.86% 39
2018
Q3 		$1.1M Sell
14,040
-3,041
-18% -$217K 0.82% 42
2018
Q2 		$1.1M Hold
17,081
– – 0.87% 42
2018
Q1 		$1.06M Sell
17,081
-967
-5% -$69.4K 0.85% 43
2017
Q4 		$1.31M Sell
18,048
-1,785
-9% -$130K 1.04% 34
2017
Q3 		$1.51M Sell
19,833
-475
-2% -$37.6K 1.26% 31
2017
Q2 		$1.63M Buy
+20,308
New +$1.6M 1.47% 28

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Abbot Financial Management's CVS Position: Q2 2024 in Review

Abbot Financial Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 9,952 shares — an estimated $794K sold.

Abbot Financial Management first reported a position in CVS in Q2 2017 and held it in 28 quarters. The position peaked at $2.17M in Q1 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Abbot Financial Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Abbot Financial Management sold 9,952 CVS Health shares in Q2 2024, an estimated $794K.
  • Abbot Financial Management first reported a position in CVS Health in Q2 2017 and held it in 28 quarters.
  • Abbot Financial Management's CVS Health position peaked at $2.17M in Q1 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Abbot Financial Management's 13F filing for Q2 2024, filed 9 Aug 2024.